NCT07134504

Brief Summary

A 66-year-old male known case of diabetes and hypertension presented to the urology clinic with a 2-month history of lower urinary tract symptoms (LUTS), particularly poor flow, sense of incomplete bladder emptying, dysuria and hesitancy. Family history was negative for prostate or breast cancer. On examination, there were signs of anaemia or lymphadenopathy. His abdominal examination was unremarkable with no hepatosplenomegaly, and his digital rectal examination (DRE) revealed an irregular, moderately enlarged nodular prostate.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 20, 2025

Completed
10 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2025

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

August 13, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 21, 2025

Completed
Last Updated

August 21, 2025

Status Verified

May 1, 2025

Enrollment Period

10 days

First QC Date

August 13, 2025

Last Update Submit

August 19, 2025

Conditions

Prostate Cancer

Keywords

lymphomadiffuse large B cellurinary tract symptoms

Outcome Measures

Primary Outcomes (1)

  • cancer specific survival

    cancer specific survival with R-CHOP

    through the end of 6 cycles of R-CHOP an average of 6 months

Eligibility Criteria

Sexmale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

66 Year old male.

You may qualify if:

  • \- Patient with primary diffuse large B cell lymphoma

You may not qualify if:

  • Patient with without primary diffuse large B cell lymphoma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IMSS

Colonia del Valle, D.F, 29060, Mexico

Location

Related Publications (1)

  • Bal S, Odujoko O, Fiedler J, Sieber SC, Beck E, Gupta G. Primary follicular lymphoma of the prostate co-existing with grade group 5 prostatic adenocarcinoma and presenting as a PI-RADS lesion 4 on mpMRI. Urol Case Rep. 2024 Mar 12;54:102708. doi: 10.1016/j.eucr.2024.102708. eCollection 2024 May.

    PMID: 38550656BACKGROUND

MeSH Terms

Conditions

Prostatic NeoplasmsLymphoma

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital DiseasesNeoplasms by Histologic TypeLymphoproliferative DisordersLymphatic DiseasesHemic and Lymphatic DiseasesImmunoproliferative DisordersImmune System Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PHD

Study Record Dates

First Submitted

August 13, 2025

First Posted

August 21, 2025

Study Start

July 20, 2025

Primary Completion

July 30, 2025

Study Completion

August 1, 2025

Last Updated

August 21, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

anyone who ask via e-mail

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
anytime
Access Criteria
e-mail

Locations

ME(1)